专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

71. 发明申请

US20130149398A1 COMPOSITIONS OF HERBAL FORMULATIONS AND USES THEREOF 有权
公开(公告)号：US20130149398A1
公开(公告)日：2013-06-13
申请号：US13471913
申请日：2012-05-15
申请人： Tomy YESUDAS , Philip ALEX , Michael CENTOLA , Adam Joshua PAYNE
发明人： Tomy YESUDAS , Philip ALEX , Michael CENTOLA , Adam Joshua PAYNE
IPC分类号： A61K36/90 , A61K36/185 , A61K36/22 , A61K36/71 , A61K36/899 , A61K36/31 , A61K36/76 , A61K36/66 , A61K36/29 , A61K36/48 , A61K36/28 , A61K36/27 , A61K36/68 , A61K36/77 , A61K36/23
CPC分类号： A61K36/90 , A61K36/185 , A61K36/22 , A61K36/23 , A61K36/24 , A61K36/27 , A61K36/28 , A61K36/29 , A61K36/31 , A61K36/35 , A61K36/48 , A61K36/66 , A61K36/68 , A61K36/71 , A61K36/76 , A61K36/77 , A61K36/808 , A61K36/899 , A61K2300/00
摘要： Disclosed herein are herbal formulations for relief from symptoms of skin disease. The formulations can also be combined with an active or inactive pharmaceutical ingredient, and/or a pharmaceutically acceptable excipient.

72. 发明申请

US20100112099A1 PHYTOCHEMICAL COMPOSITIONS AND METHODS FOR ACTIVATING AMP-KINASE 审中-公开
标题翻译：生物化学组合物和激活AMP-激酶的方法
公开(公告)号：US20100112099A1
公开(公告)日：2010-05-06
申请号：US12612249
申请日：2009-11-04
申请人： Matthew L. Tripp , John G. Babish , Linda Pacioretty , Jeffrey S. Bland
发明人： Matthew L. Tripp , John G. Babish , Linda Pacioretty , Jeffrey S. Bland
IPC分类号： A61K36/00 , A61K36/82 , A61K36/27 , A61K36/45 , A61K36/752 , A61K36/906 , A61K38/00
CPC分类号： A61K36/9068 , A61K36/185 , A61K36/22 , A61K36/27 , A61K36/33 , A61K36/35 , A61K36/48 , A61K36/61 , A61K36/71 , A61K36/73 , A61K36/738 , A61K36/82 , A61K36/87 , A61K36/9066 , A61K38/018
摘要： The present invention relates to AMPK activation utilizing phytochemicals, natural plant extracts and combinations. Disclosed are methods, compounds, and compositions comprising drugs, medical foods, and dietary supplements for the prevention and treatment of metabolic disorders, in particular obesity, weight gain, insulin resistance syndromes, diabetes, fasting hyperlipidemia and osteoarthritis. More specifically, the invention relates to pharmaceutical therapeutic methods and compositions utilizing phytochemicals, natural plant extracts and combinations to modify myocyte, hepatocyte, adipocyte, cardiac or pancreatic physiology through activation of AMPK.
摘要翻译：本发明涉及利用植物化学物质，天然植物提取物和组合的AMPK活化。公开了包含用于预防和治疗代谢紊乱，特别是肥胖，体重增加，胰岛素抵抗综合征，糖尿病，禁食性高脂血症和骨关节炎的药物，医疗食品和膳食补充剂的方法，化合物和组合物。更具体地，本发明涉及利用植物化学物质，天然植物提取物和组合来通过激活AMPK来改变肌细胞，肝细胞，脂肪细胞，心脏或胰腺生理学的药物治疗方法和组合物。

73. 发明申请

US20070166390A1 METHOD FOR CANCER THERAPY USING HERBAL EXTRACTS 失效
标题翻译：使用草药提取物治疗癌症的方法
公开(公告)号：US20070166390A1
公开(公告)日：2007-07-19
申请号：US11627655
申请日：2007-01-26
申请人： Peter Grandics , Joe Holbrook
发明人： Peter Grandics , Joe Holbrook
IPC分类号： A61K36/27 , A61K35/20 , A61K33/36 , A61K33/04 , A61K36/736 , A61K36/899 , A61K36/81 , A61K36/73 , A61K31/525 , A61K31/714
CPC分类号： A61K35/20 , A61K31/525 , A61K31/714 , A61K33/04 , A61K36/27 , A61K36/73 , A61K36/736 , A61K36/81 , A61K36/899 , A61K45/06 , A61K2300/00
摘要： A new method is described for the treatment of cancer. In one alternative, the method utilizes two main compositions. The first composition is Soma, a healing herb described in the Rig Veda, the sacred scriptures of the Hindus. The second composition is a composite of plant-derived substances and a mineral. When they are administered to cancer patients following the recommended therapeutic regimen, regression of the cancer results. Alternatively, the second composition can be used alone.
摘要翻译：描述了治疗癌症的新方法。在一种替代方案中，该方法利用两种主要组成。第一个组合是Soma，在Rig Veda中描述的治疗草药，是印度教徒的神圣经文。第二组合物是植物衍生物质和矿物的复合物。当按照推荐的治疗方案给予癌症患者时，癌症的消退结果。或者，第二组合物可以单独使用。

74. 发明授权

US06913772B2 Composition useful as hepatoprotectants comprising extract of plant Cryptolepis buchanani and a method thereof 有权
标题翻译：可用作包含植物Cryptolepis buchanani的提取物的肝脏保护剂的组合物及其方法
公开(公告)号：US06913772B2
公开(公告)日：2005-07-05
申请号：US10735437
申请日：2003-12-11
申请人： Ghulam Nabi Qazi , Bupinder Singh Jaggi , Bal Krishan Chandan , Krishan Avtar Suri , Naresh Kumar Satti , Rakesh Maurya , Lila Ram Manhas , Ashwani Kumar , Bal Krishan Kapahi
发明人： Ghulam Nabi Qazi , Bupinder Singh Jaggi , Bal Krishan Chandan , Krishan Avtar Suri , Naresh Kumar Satti , Rakesh Maurya , Lila Ram Manhas , Ashwani Kumar , Bal Krishan Kapahi
IPC分类号： A01N25/00 , A01N27/00 , A01N65/00 , A61K31/4745 , A61K31/70 , A61K36/27 , A61K35/78
CPC分类号： A61K36/27 , Y10S514/885 , Y10S514/893 , Y10S514/894
摘要： The present invention relates to a composition useful for hepatoprotection, said composition comprising polar extract of plant Cryptolepis Buchanani and/or fractions of the said extract, and optionally pharmaceutically acceptable additives and a method of producing said composition and also a method of treating a subject using said composition.
摘要翻译：本发明涉及一种可用于肝保护的组合物，所述组合物包含植物Cryptolepis Buchanani的极性提取物和/或所述提取物的级分，和任选的药学上可接受的添加剂和制备所述组合物的方法，以及使用所说的组合。

75. 发明申请

US20050053555A1 Appetite control compositions and methods of use 审中-公开
标题翻译：食欲控制组合物和使用方法
公开(公告)号：US20050053555A1
公开(公告)日：2005-03-10
申请号：US10891712
申请日：2004-07-14
申请人： Mark Pederson
发明人： Mark Pederson
IPC分类号： A23G3/48 , A23L1/30 , A61K9/68 , A61K36/10 , A61K36/27 , A61K36/484 , A61K45/06 , A61K35/78
CPC分类号： A23G3/48 , A23L33/105 , A23V2002/00 , A61K36/27 , A61K36/484 , A61K45/06 , A61K2300/00 , A23V2200/332 , A23V2250/252 , A23V2250/21
摘要： Appetite control compositions comprise Gymnema sylvestre and an expectorant. In some embodiments, the appetite control compositions contain from about 3 mg to about 50 mg of gymnemic acid (an extract of Gymnema sylvestre), from about 10 mg to about 80 mg of glycyrrhizin (an extract of Glycyrrhiza glabra), high impact flavor, and a sweetening agent in a non-traditional dosage form. A non-traditional dosage form provides for the topical application of medicaments to the tissues of the mouth and tongue, more specifically, to the sweetness taste receptors of the tongue. By delivering gymnemic acid to the sweetness receptors of the tongue, the sensation of sweetness is blocked, thereby providing appetite control.
摘要翻译：食欲控制组合物包括麝香维生素和祛痰剂。在一些实施方案中，食欲控制组合物含有约3mg至约50mg的肌肉酸（Gymnema sylvestre的提取物），约10mg至约80mg的甘草甜素（甘草的提取物），高抗风味剂，和非传统剂型的甜味剂。非传统剂型提供药物在嘴和舌的组织中的局部应用，更具体地说是舌头的甜味受体。通过向舌头的甜味受体输送体液酸，阻止甜味的感觉，从而提供食欲控制。

76. 发明申请

US20050008726A1 Compositions incorporating (-)-hydroxycitric acid, chromium, and gymnemic acid, and related methods for promoting healthy body weight and improving related health factors 审中-公开
公开(公告)号：US20050008726A1
公开(公告)日：2005-01-13
申请号：US10911181
申请日：2004-08-03
申请人： Debasis Bagchi , Harry Preuss
发明人： Debasis Bagchi , Harry Preuss
IPC分类号： A23L1/30 , A23L1/304 , A61K31/19 , A61K31/194 , A61K31/555 , A61K31/704 , A61K33/24 , A61K36/18 , A61K36/27 , A61K36/38 , A61P3/04 , A61P3/06 , A61K35/78
CPC分类号： A61K31/19 , A23L33/105 , A23L33/165 , A23V2002/00 , A61K31/194 , A61K31/555 , A61K31/704 , A61K33/24 , A61K36/27 , A61K36/38 , A61K2300/00 , A23V2250/21 , A23V2250/1586
摘要： Methods for promoting healthy body weight and improving a variety of related physiological factors, including serum serotonin levels, serum leptin levels, fat oxidation, cholesterol levels, and body mass index, in persons or other mammals, include administering to those persons or other mammals effective amounts of hydroxycitric acid or a combination of hydroxycitric acid, chromium and gymnemic acid, which work synergistically to further to promote healthy body weight and improve these physiological factors.

77. 发明授权

US5886029A Method and composition for treatment of diabetes 失效
标题翻译：治疗糖尿病的方法和组成
公开(公告)号：US5886029A
公开(公告)日：1999-03-23
申请号：US924512
申请日：1997-09-05
申请人： Kirpal S. Dhaliwal
发明人： Kirpal S. Dhaliwal
IPC分类号： A61K31/35 , A61K36/27 , A61K36/42 , A61K36/48 , A61K36/54 , A61K36/58 , A61K36/59 , A61K36/60 , A61K36/61 , A61K36/75 , A61K35/78
CPC分类号： A61K36/61 , A61K36/27 , A61K36/42 , A61K36/48 , A61K36/54 , A61K36/58 , A61K36/59 , A61K36/60 , A61K36/75 , Y10S514/866
摘要： A medicinal composition is provided for treatment of diabetes in a human subject. The medicinal composition of the invention induces a significant reduction in serum glucose due to the regeneration of pancreatic islet cells. A medicinal composition according to the invention necessarily includes a pharmacologically significant quantity of (-)epicatechin augmented with a comparable amount of gymnemic acid. For best results smaller quantities of cinnamomum tamala, syzygium cumini, trigonella foenum graceum, azardichta indica, ficus racemosa, and tinospora cordifolia are also included in the composition. One to two grams of the medicinal composition of the invention are administered to a diabetic human subject three times a day before meals. The unique combination of components in the medicinal composition leads to a regeneration of the pancreas cells which then start producing insulin on their own. Since the composition restores normal pancreatic function, treatment can be discontinued after between about four and twelve months.
摘要翻译：提供用于治疗人类受试者的糖尿病的药物组合物。本发明的药物组合物由于胰岛细胞的再生而引起血清葡萄糖的显着降低。根据本发明的药物组合物必须包括药理学上显着量的（ - ）表儿茶素，其具有相当量的体酸。为了获得最佳结果，组合物中还包括较少数量的肉桂，马铃薯umin i，枸杞，楝树，榕果和西孢子。将1至2克本发明的药物组合物在饭前一天给予糖尿病人受试者3次。药物组合物中组分的独特组合导致胰腺细胞的再生，然后胰腺自身开始产生胰岛素。由于组合物恢复正常的胰腺功能，治疗可以在约4至12个月后停止。

78. 发明授权

US5628999A Hypoglycemic agent from cryptolepis 失效
公开(公告)号：US5628999A
公开(公告)日：1997-05-13
申请号：US470876
申请日：1995-06-06
申请人： Jian Luo , Diana M. Fort , Donald E. Bierer , Reimar C. Bruening , Steven R. King , Thomas J. Carlson
发明人： Jian Luo , Diana M. Fort , Donald E. Bierer , Reimar C. Bruening , Steven R. King , Thomas J. Carlson
IPC分类号： A61K31/4745 , A61K31/475 , A61K31/64 , A61K31/715 , A61K36/27 , A61K38/28 , C07D471/04 , C07D471/16 , A61K35/78
CPC分类号： A61K31/475 , A61K31/4745 , A61K31/64 , A61K31/7004 , A61K31/715 , A61K36/27 , A61K38/28 , C07D471/04 , Y10S514/866 , Y10S514/884
摘要： The use of extracts from Cryptolepis sp. or quindoline alkaloids such quindoline and cryptolepine contained therein as hypoglycemic agents, as well as methods for obtaining the hypoglycemic agents are described. According to a preferred embodiment, the extracts are derived from Cryptolepis sanguinolenta. As hypoglycemic agents, the extracts or quindoline alkaloids such as quindoline or cryptolepine are useful for treating insulin-dependent (type I) and non-insulin-dependent (type II) diabetes.

79. 发明授权

US4761286A Intestinal absorption inhibiting agent 失效
标题翻译：肠吸收抑制剂
公开(公告)号：US4761286A
公开(公告)日：1988-08-02
申请号：US8081
申请日：1987-01-27
申请人： Yasutake Hiji
发明人： Yasutake Hiji
IPC分类号： A23L1/307 , A23G3/00 , A23G3/42 , A23L1/30 , A23L2/38 , A61K36/00 , A61K36/18 , A61K36/27 , A61K35/78
CPC分类号： A23G3/42 , A61K36/27 , Y10S426/804
摘要： Gymnema sylvestre is added to glucose for inhibiting absorption of the glucose through intestine, whereby the increase in calorie intake which usually arises from taking of glucose-containing foodstuffs can be restrained at a low level.
摘要翻译：将葡萄糖is蓉添加到葡萄糖中，通过肠抑制葡萄糖的吸收，通常由摄取含葡萄糖的食物引起的卡路里摄取量的增加可以被抑制在较低的水平。

80. 发明公开

US20230302074A1 Methods for Treating Neurological Disorders Using Nutrient Compositions 审中-公开
公开(公告)号：US20230302074A1
公开(公告)日：2023-09-28
申请号：US18204044
申请日：2023-05-31
申请人： LISA GENG
发明人： LISA GENG
IPC分类号： A61K36/185 , A61K36/27 , A61K36/328 , A61K36/9066 , A61K36/82 , A61K36/54 , A61K36/81 , A23L33/105 , A23L33/12 , A61P25/28 , A61K31/07 , A61K31/197 , A61K31/198 , A61K31/202 , A61K31/205 , A61K31/355 , A61K31/375 , A61K31/4188 , A61K31/4415 , A61K31/455 , A61K31/51 , A61K31/519 , A61K31/525 , A61K31/593 , A61K31/714 , A61K33/04 , A61K33/06 , A61K33/24 , A61K33/30 , A61K33/32 , A61K33/34 , A61K35/20 , A61K36/24 , A23L33/00 , A23L27/10 , A23L27/12
CPC分类号： A61K36/185 , A61K36/27 , A61K36/328 , A61K36/9066 , A61K36/82 , A61K36/54 , A61K36/81 , A23L33/105 , A23L33/12 , A61P25/28 , A61K31/07 , A61K31/197 , A61K31/198 , A61K31/202 , A61K31/205 , A61K31/355 , A61K31/375 , A61K31/4188 , A61K31/4415 , A61K31/455 , A61K31/51 , A61K31/519 , A61K31/525 , A61K31/593 , A61K31/714 , A61K33/04 , A61K33/06 , A61K33/24 , A61K33/30 , A61K33/32 , A61K33/34 , A61K35/20 , A61K36/24 , A23L33/30 , A23L27/10 , A23L27/12 , A23V2002/00
摘要： Nutrient compositions comprising botanical extracts and methods of their use for treating, inter alia, autism or apraxia and/or ameliorating one or more symptoms thereof are disclosed. The use of such compositions for enhancing cognitive function and/or one or more aspects thereof, or for treating stroke or seizures and/or ameliorating one or more symptoms thereof are also disclosed.

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式